Which has grown faster, ADMA or BEAM?

Over the past five years, BEAM grew revenue faster — ADMA at a 54.55% CAGR versus BEAM at 479.04%.

Is ADMA or BEAM more profitable?

ADMA runs the higher net margin — ADMA at 32.98% versus BEAM at -54.75%.

How have ADMA and BEAM total returns compared?

Over the past 5 years, ADMA delivered 54.74% and BEAM delivered -21.41% annualized total return. Past performance doesn't predict future results.

ADMA Biologics, Inc. (ADMA) vs Beam Therapeutics Inc. (BEAM)

A side-by-side comparison of ADMA Biologics, Inc. and Beam Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADMA

ADMA Biologics, Inc.

$2.38B

$10.26HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT

BEAM

Beam Therapeutics Inc.

$2.60B

$25.24HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — ADMA vs BEAM

growth of $100 · dividends reinvested · last 7y

ADMA +155.3% (+14.3%/yr)BEAM +36.9% (+4.6%/yr)ADMA compounded faster over this window

ADMA BEAM

ADMA vs BEAM: by the numbers

•BEAM is the larger company ($2.60B vs $2.38B market cap).
•ADMA is profitable (32.98% net margin) while BEAM runs a net loss (-54.75%).
•BEAM grew revenue faster over the past five years (479.04% vs 54.55% CAGR).

Metrics side by side

Valuation

Metric	ADMA	BEAM
P/E ratio	14.65	N/A
Forward P/E	12.87	N/A
P/S ratio	4.64	16.64
P/B ratio	5.82	2.43
EV / EBITDA	10.82	N/A
FCF yield	4.90%	N/A

Profitability

Metric	ADMA	BEAM
Gross margin	64.71%	84.05%
Operating margin	42.26%	-274.57%
Net margin	32.98%	-54.75%
ROE	41.39%	-8.00%
ROIC	27.60%	-28.96%

Growth (annualized)

Metric	ADMA	BEAM
Revenue CAGR (5Y)	54.55%	479.04%
Total return CAGR (5Y)	54.74%	-21.41%

Frequently asked

Which has grown faster, ADMA or BEAM?: Over the past five years, BEAM grew revenue faster — ADMA at a 54.55% CAGR versus BEAM at 479.04%.
Is ADMA or BEAM more profitable?: ADMA runs the higher net margin — ADMA at 32.98% versus BEAM at -54.75%.
How have ADMA and BEAM total returns compared?: Over the past 5 years, ADMA delivered 54.74% and BEAM delivered -21.41% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADMA analysis Full BEAM analysis Interactive comparison tool

Dig into the metrics

ADMA Biologics P/E ratio ADMA Biologics ROE Beam Therapeutics ROE ADMA Biologics operating margin Beam Therapeutics operating margin ADMA Biologics revenue growth Beam Therapeutics revenue growth ADMA Biologics free cash flow Beam Therapeutics free cash flow

ADMA Biologics & Beam Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.